Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menko-Jan de Boer

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
Journal of Thrombosis and Thrombolysis|March 6, 2007
Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparisonSaman Rasoul, Jan Paul Ottervanger, Menko Jan de Boer, et al.
American Heart Journal|March 29, 2008
Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarctionMark B Nienhuis, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Journal of Thrombosis and Thrombolysis|December 22, 2007
Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Harry Suryapranata, Menko-Jan de Boer, et al.
International Journal of Cardiology|December 31, 2010
Poor outcome after recurrent acute myocardial infarction: a plea for optimal secondary preventionSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 31, 2006
Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vesselsGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Heart (British Cardiac Society)|February 1, 2020
Exercise and myocardial injury in hypertrophic cardiomyopathyG Etienne Cramer, D H Frank Gommans, Hendrik-Jan Dieker, et al.
The American Journal of Cardiology|June 14, 2005
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
Atherosclerosis|July 11, 2006
Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
The American Journal of Clinical Nutrition|October 23, 2015
Healthy eating and lower mortality risk in a large cohort of cardiac patients who received state-of-the-art drug treatmentFemke P C Sijtsma, Sabita S Soedamah-Muthu, Janette de Goede, et al.
European Journal of Heart Failure|June 12, 2003
The prognostic importance of heart failure and age in patients treated with primary angioplastyJose P S Henriques, Felix Zijlstra, Menko-Jan de Boer, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
Journal of Thrombosis and Thrombolysis|March 6, 2007
Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparisonSaman Rasoul, Jan Paul Ottervanger, Menko Jan de Boer, et al.
American Heart Journal|March 29, 2008
Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarctionMark B Nienhuis, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Journal of Thrombosis and Thrombolysis|December 22, 2007
Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Harry Suryapranata, Menko-Jan de Boer, et al.
International Journal of Cardiology|December 31, 2010
Poor outcome after recurrent acute myocardial infarction: a plea for optimal secondary preventionSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 31, 2006
Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vesselsGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Heart (British Cardiac Society)|February 1, 2020
Exercise and myocardial injury in hypertrophic cardiomyopathyG Etienne Cramer, D H Frank Gommans, Hendrik-Jan Dieker, et al.
The American Journal of Cardiology|June 14, 2005
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
Atherosclerosis|July 11, 2006
Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
The American Journal of Clinical Nutrition|October 23, 2015
Healthy eating and lower mortality risk in a large cohort of cardiac patients who received state-of-the-art drug treatmentFemke P C Sijtsma, Sabita S Soedamah-Muthu, Janette de Goede, et al.
European Journal of Heart Failure|June 12, 2003
The prognostic importance of heart failure and age in patients treated with primary angioplastyJose P S Henriques, Felix Zijlstra, Menko-Jan de Boer, et al.
Pageof 14